Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.
Kassis
Christelle
C
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Champlin
Richard E
RE
Hachem
Ray Y
RY
Hosing
Chitra
C
Tarrand
Jeffrey J
JJ
Perego
Cheryl A
CA
Neumann
Joyce L
JL
Raad
Issam I
II
Chemaly
Roy F
RF
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D003428:Cross Infection / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D017053:Infection Control / Q000379:methods*; D008297:Male; D008875:Middle Aged; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab